<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04694950</url>
  </required_header>
  <id_info>
    <org_study_id>210101</org_study_id>
    <nct_id>NCT04694950</nct_id>
  </id_info>
  <brief_title>Postoperative Recovery and Comfort in Patients Undergoing Urologic Robotic Surgery</brief_title>
  <official_title>Postoperative Recovery and Comfort After Urologic Robotic Surgery: A Feasibility Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Linkoeping University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Linkoeping University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Previously published studies show that adding intrathecal morphine to general anesthesia can&#xD;
      reduce the postoperative pain and length of stay (LOS) in varies types of surgery. A recent&#xD;
      meta-analysis showed that the addition of intrathecal morphine at doses below 500µg did not&#xD;
      increase the risk of respiratory depression compared with a control group receiving&#xD;
      intravenous opioids. Epidural analgesia is uncommonly used for robot-assisted laparoscopic&#xD;
      procedures due to the limited surgical trauma. In addition, the risks associated with the&#xD;
      epidural itself such as infection and spinal hematoma are thought to outweigh its possible&#xD;
      benefits for these procedures.&#xD;
&#xD;
      At Linkoping University Hospital a combination of general anesthesia and intrathecal morphine&#xD;
      in robot-assisted laparoscopic radical prostatectomy and in robotic-assisted laparoscopic&#xD;
      cystectomy is now routinely used in order to improve postoperative recovery. However whether&#xD;
      this approach is beneficial in other types of robotic-assisted urological procedures is&#xD;
      unknown.&#xD;
&#xD;
      Therefore the investigators aim to conduct a feasibility study for the use of intrathecal&#xD;
      morphine combined with general anaesthesia in adult patients undergoing elective urologic&#xD;
      laparoscopic robot-assisted surgery at Linkoping University Hospital. The investigators will&#xD;
      include 30 patients in the study. The specific aims are to investigate the feasibility and&#xD;
      sensitivity of Quality of Recovery 15 (QoR15), as an outcome tool measuring postoperative&#xD;
      well-being in this patient cohort.&#xD;
&#xD;
      The investigators will also investigate the feasibility of other outcome measures such as&#xD;
      postoperative pain, post-anesthesia care unit LOS, occurrence of pruritus and hospital LOS.&#xD;
&#xD;
      For planning of the timeframe of the future interventional study the investigators will use&#xD;
      this feasibility study to examine the inclusion rate of study patients.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">December 30, 2020</start_date>
  <completion_date type="Anticipated">December 30, 2021</completion_date>
  <primary_completion_date type="Anticipated">November 30, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Change in Quality of Recovery 15 (QoR-15) score</measure>
    <time_frame>Preoperative, postoperative up to day 7</time_frame>
    <description>Quality of Recovery 15. A total of 15 questions each answered with a value from 0 to 10. The minimum value of the QoR-15 is 0 and the maximum value is 150. A higher value means a better outcome.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Postoperative pain</measure>
    <time_frame>Up to postoperative day 3</time_frame>
    <description>Measurement of pain in rest and in movement with the Numeric Rating Scale (NRS) Pain Scale. Minimum value is 0 (no pain) and maximum value is 10 (extreme pain).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>PONV</measure>
    <time_frame>Up to postoperative day 3</time_frame>
    <description>Measurement of the frequency of postoperative nausea and vomiting (PONV).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Return of bowel function</measure>
    <time_frame>Up to postoperative day 7</time_frame>
    <description>Time to first passing of flatus and first passing of stool.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative complications</measure>
    <time_frame>Up to postoperative day 30</time_frame>
    <description>Using the Clavien-Dindo Classification</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Length of hospital stay</measure>
    <time_frame>Up to 30 days</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Quality of Recovery</condition>
  <condition>Urology</condition>
  <condition>Pain</condition>
  <condition>PONV</condition>
  <condition>Postoperative Complications</condition>
  <condition>Laparoscopic</condition>
  <arm_group>
    <arm_group_label>Group feasibility</arm_group_label>
    <description>Adults undergoing elective urologic laparoscopic robotic surgery.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Usual care</intervention_name>
    <description>Intravenous morphine according to clinician´s discretion.</description>
    <arm_group_label>Group feasibility</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Adult population undergoing elective urologic robotic assisted laparoscopic surgery in&#xD;
        Linkoping University Hospital, sweden.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Scheduled for elective urologic robotic assisted laparoscopic surgery in Linkoping&#xD;
             University Hospital&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Age &lt;18&#xD;
&#xD;
          -  Not expected to comprehend the written or verbal study information&#xD;
&#xD;
          -  Patient planned for robotic assisted laparoscoic prostatectomy or robotic assisted&#xD;
             laparoscopic cystectomy&#xD;
&#xD;
          -  Acute surgery&#xD;
&#xD;
          -  ASA class &gt;3&#xD;
&#xD;
          -  Major surgery on another organ planned at the same operation&#xD;
&#xD;
          -  Patient planned for a neuraxial blockade in addition to general anaesthesia.&#xD;
&#xD;
          -  Study personal not available&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Michelle Chew, MD PhD</last_name>
    <role>Study Director</role>
    <affiliation>Linkoping University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Martin Holmberg, MD</last_name>
    <phone>+46702767941</phone>
    <email>martin.holmberg@regionostergotland.se</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Hans Bahlmann, MD PhD</last_name>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Linkoping University Hospital</name>
      <address>
        <city>Linköping</city>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Martin Holmberg, MD</last_name>
      <phone>+46702767941</phone>
      <email>martin.holmberg@regionostergotland.se</email>
    </contact>
  </location>
  <location_countries>
    <country>Sweden</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>December 29, 2020</study_first_submitted>
  <study_first_submitted_qc>January 4, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">January 5, 2021</study_first_posted>
  <last_update_submitted>October 12, 2021</last_update_submitted>
  <last_update_submitted_qc>October 12, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 14, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Linkoeping University</investigator_affiliation>
    <investigator_full_name>Martin Holmberg</investigator_full_name>
    <investigator_title>Principal investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Postoperative Complications</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

